NCT01104337View on ClinicalTrials.gov

Drug Interaction Between Paracetamol and Warfarin

PHASE4CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

November 30, 2008

Study Completion Date

February 28, 2010

Conditions
Deep Venous ThrombosisPulmonary EmbolismAtrial FibrillationStrokeAntiphospholipid Syndrome
Interventions
DRUG

paracetamol

Treatment consisted of two paracetamol 500mg (Doliprane® 500mg, Sanofi-aventis, Paris, France) tablets twice a day along with two matching placebo tablets once daily

DRUG

paracetamol

Treatment consisted of two paracetamol 500mg (Doliprane® 500mg, Sanofi-aventis, Paris, France) tablets three times a day

DRUG

Placebo

Treatment consisted of two matching placebo tablets three times a day.

Trial Locations (1)

75010

Therapeutic Research Unit, Department of Internal Medicine, Hospital Lariboière, Paris

All Listed Sponsors
lead

Hopital Lariboisière

OTHER

NCT01104337 - Drug Interaction Between Paracetamol and Warfarin | Biotech Hunter | Biotech Hunter